The Motley Fool··Reuben Gregg BrewerPfizer's 6.4% Dividend Yield Attracts Income Investors Despite Sector Headwinds
Pfizer's 6.4% dividend yield attracts income investors, but structural challenges like patent expirations and a payout ratio exceeding 100% present execution risks.
PFEdividend yieldincome investing